Winton Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $340K | Sell |
|
|||||
|
2024
Q2 | $641K | Sell |
|
|||||
|
2024
Q1 | $673K | Buy |
|
|||||
|
2023
Q4 | $477K | Buy |
|
|||||
|
2023
Q3 | $378K | Buy |
|
|||||
|
2023
Q2 | $561K | Buy |
|
|||||
|
2023
Q1 | $447K | Sell |
|
|||||
|
2022
Q4 | $524K | Buy |
|
|||||
|
2022
Q3 | $527K | Sell |
|
|||||
|
2022
Q2 | $841K | Buy |
|
|||||
|
2022
Q1 | $872K | Buy |
|
|||||
|
2021
Q4 | $895K | Sell |
|
|||||
|
2021
Q3 | $1.21M | Sell |
|
|||||
|
2021
Q2 | $1.75M | Sell |
|
|||||
|
2021
Q1 | $1.35M | Sell |
|
|||||
|
2020
Q4 | $1.3M | Sell |
|
|||||
|
2020
Q3 | $2.68M | Sell |
|
|||||
|
2020
Q2 | $6.7M | Buy |
|
|||||
|
2020
Q1 | $5.84M | Buy |
|
|||||
|
2019
Q4 | $9.07M | Buy |
|
|||||
|
2019
Q3 | $305K | Buy |
|